A detailed history of Gts Securities LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 15,100 shares of GH stock, worth $493,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,100
Previous 21,900 31.05%
Holding current value
$493,015
Previous $632,000 45.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $154,995 - $307,096
9,645 Added 99.37%
19,351 $558,000
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $166,263 - $261,188
9,706 New
9,706 $200,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.